Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2021-12-15

Clinical Trial Update: Assessment of Intravenous Rate Control Response in Atrial Fibrillation Trial (AIRCRAFT) [Phase 4]

View source ↗

Summary

Phase 4 trial AIRCRAFT evaluating intravenous rate control in atrial fibrillation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Boston University | Conditions: Atrial Fibrillation | Phase 4 | Status: WITHDRAWN